DK2616486T3 - FACTOR VIII VARIATIONS WITH DISABLED CELLULAR ADMISSION - Google Patents

FACTOR VIII VARIATIONS WITH DISABLED CELLULAR ADMISSION Download PDF

Info

Publication number
DK2616486T3
DK2616486T3 DK11769805.0T DK11769805T DK2616486T3 DK 2616486 T3 DK2616486 T3 DK 2616486T3 DK 11769805 T DK11769805 T DK 11769805T DK 2616486 T3 DK2616486 T3 DK 2616486T3
Authority
DK
Denmark
Prior art keywords
leu
ser
glu
val
thr
Prior art date
Application number
DK11769805.0T
Other languages
Danish (da)
English (en)
Inventor
Alexander Benjamin Meijer
Koenraad Mertens
Ole Hvilsted Olsen
Kasper Lamberth
Peder Lisby Noerby
Laust Bruun Johnsen
Marianne Kjalke
Henning Ralf Stennicke
Johannes Jacobus Voorberg
Den Biggelaar Maartje Van
Henriët Meems
Original Assignee
Stichting Sanquin Bloedvoorziening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Sanquin Bloedvoorziening filed Critical Stichting Sanquin Bloedvoorziening
Priority claimed from PCT/EP2011/065913 external-priority patent/WO2012035050A2/en
Application granted granted Critical
Publication of DK2616486T3 publication Critical patent/DK2616486T3/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
DK11769805.0T 2010-09-15 2011-09-14 FACTOR VIII VARIATIONS WITH DISABLED CELLULAR ADMISSION DK2616486T3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10176731 2010-09-15
US38473110P 2010-09-21 2010-09-21
EP11173768 2011-07-13
US201161507666P 2011-07-14 2011-07-14
PCT/EP2011/065913 WO2012035050A2 (en) 2010-09-15 2011-09-14 Factor viii variants having a decreased cellular uptake

Publications (1)

Publication Number Publication Date
DK2616486T3 true DK2616486T3 (en) 2019-03-18

Family

ID=65721669

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11769805.0T DK2616486T3 (en) 2010-09-15 2011-09-14 FACTOR VIII VARIATIONS WITH DISABLED CELLULAR ADMISSION

Country Status (3)

Country Link
DK (1) DK2616486T3 (lt)
ES (1) ES2712575T3 (lt)
LT (1) LT2616486T (lt)

Also Published As

Publication number Publication date
LT2616486T (lt) 2019-03-25
ES2712575T3 (es) 2019-05-13

Similar Documents

Publication Publication Date Title
US10906960B2 (en) Factor VIII variants having a decreased cellular uptake
US9125890B2 (en) Compounds suitable for treatment of haemophilia
US20160120954A1 (en) Pharmaceutical Composition Suitable for Treatment of Haemophilia
US20160264645A1 (en) Stabilized Factor VIII Variants
US20160207977A1 (en) Compounds Suitable for Treatment of Haemophilia
EP3549953A1 (en) Recombinant factor viii proteins
JP2010202664A (ja) 第ｖｉｉｉ因子と低密度リポタンパク質レセプター関連タンパク質との相互作用のアンタゴニスト
EP3003368A2 (en) Anti-gpiib/iiia antibodies or uses thereof
DK2616486T3 (en) FACTOR VIII VARIATIONS WITH DISABLED CELLULAR ADMISSION
Ito et al. Removal of single‐site N‐linked glycans on factor VIII alters binding of domain‐specific monoclonal antibodies
AU2013204897A1 (en) Factor VIII variants having a decreased cellular uptake